Phase II, Open-Label Study to Evaluate Lazanda in Cancer Patients Receiving Palliative Radiation
Phase of Trial: Phase II
Latest Information Update: 24 Jul 2019
Price : $35 *
At a glance
- Drugs Fentanyl (Primary)
- Indications Bone metastases; Haematological malignancies; Solid tumours
- Focus Therapeutic Use
- 20 Mar 2018 Status changed from recruiting to discontinued.
- 01 May 2017 Status changed from not yet recruiting to recruiting.
- 09 Mar 2017 New trial record